Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001104659-23-110232
Filing Date
2023-10-20
Accepted
2023-10-19 20:14:29
Documents
1
Effectiveness Date
2023-10-20

Document Format Files

Seq Description Document Type Size
1 S-8 POS tm2328826d1_s8pos.htm S-8 POS 23246
  Complete submission text file 0001104659-23-110232.txt   24352
Mailing Address 414 COMMERCE DRIVE STE 120 FORT WASHINGTON PA 19034
Business Address 25-28 NORTH WALL QUAY DUBLIN L2 D01 H104 (610) 816-6640
Nabriva Therapeutics plc (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-208097 | Film No.: 231335801
SIC: 2834 Pharmaceutical Preparations